CSIMarket
 


Travere Therapeutics Inc   (TVTX)
Other Ticker:  
 

Travere Therapeutics Inc 's Leverage Ratio

TVTX's quarterly Leverage Ratio and Total Liabilities, Equity growth




TVTX Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -67.25 % -52.84 % -42.61 % 0.23 % -3.54 %
Y / Y Total Liabilities Change 33.75 % 80.9 % 87.93 % 48.52 % 60.48 %
Leverage Ratio MRQ 6.21 3.97 2.98 1.57 1.52
Overall Ranking # # # # #
Seq. Equity Change -35.76 % -24.71 % -31.1 % -1.71 % -7.5 %
Seq. Total Liabilities Change 0.44 % 0.41 % 30.71 % 1.46 % 35.86 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 0.44%, Leverage Ratio detoriated to 6.21, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Travere Therapeutics Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are TVTX Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Travere Therapeutics Inc 's Equity $ 101 Millions Visit TVTX's Balance sheet
Travere Therapeutics Inc 's Total Liabilities $ 626 Millions Visit TVTX's Balance sheet
Source of TVTX's Sales Visit TVTX's Sales by Geography


Cumulative Travere Therapeutics Inc 's Leverage Ratio

TVTX's Leverage Ratio for the trailling 12 Months

TVTX Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -67.25 % -52.84 % -42.61 % 0.23 % -3.54 %
Y / Y Total Liabilities TTM Growth 33.75 % 80.9 % 87.93 % 48.52 % 60.48 %
Leverage Ratio TTM 3.05 2.24 1.66 1.24 1.12
Total Ranking TTM # 2154 # 2975 # 2322 # 2387 # 758
Seq. Equity TTM Growth -35.76 % -24.71 % -31.1 % -1.71 % -7.5 %
Seq. Total Liabilities TTM Growth 0.44 % 0.41 % 30.71 % 1.46 % 35.86 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 0.44%, Leverage Ratio improved to 3.05, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 303 other companies have achieved lower Leverage Ratio than Travere Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. 2154.

Explain Leverage Ratio?
Who are TVTX Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 304
Healthcare Sector # 636
Within the Market # 2154


TTM Leverage Ratio Statistics
High Average Low
3.05 1.23 0.67
(Sep 30 2022)   (Mar 31 2017)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Madrigal Pharmaceuticals Inc   13.79 $ 147.143  Millions$ 10.670  Millions
Jaguar Health inc   13.24 $ 47.640  Millions$ 3.599  Millions
Fibrogen Inc   12.59 $ 582.531  Millions$ 46.273  Millions
Novan Inc   11.32 $ 76.510  Millions$ 6.760  Millions
Reata Pharmaceuticals Inc   11.23 $ 50.711  Millions$ 4.516  Millions
Heron Therapeutics Inc   11.11 $ 249.502  Millions$ 22.450  Millions
Allarity Therapeutics Inc   9.68 $ 14.012  Millions$ 1.447  Millions
Evelo Biosciences Inc   8.02 $ 74.825  Millions$ 9.334  Millions
Puma Biotechnology Inc   7.97 $ 176.615  Millions$ 22.155  Millions
Cytomx Therapeutics Inc   6.95 $ 198.018  Millions$ 28.474  Millions
Promis Neurosciences Inc   6.37 $ 4.652  Millions$ 0.730  Millions
Travere Therapeutics Inc   6.21 $ 625.539  Millions$ 100.676  Millions
Sarepta Therapeutics Inc   6.12 $ 2,636.065  Millions$ 430.840  Millions
Abbvie Inc   5.81 $ 93,144.000  Millions$ 16,027.000  Millions
Evolus Inc   5.60 $ 163.499  Millions$ 29.220  Millions
Scynexis Inc   5.51 $ 94.815  Millions$ 17.209  Millions
Collegium Pharmaceutical inc   5.05 $ 996.399  Millions$ 197.194  Millions
Applied Therapeutics Inc   4.83 $ 46.514  Millions$ 9.629  Millions
Gossamer Bio Inc   4.74 $ 267.187  Millions$ 56.351  Millions
Amicus Therapeutics inc   4.73 $ 626.963  Millions$ 132.565  Millions
China Pharma Holdings Inc   4.72 $ 13.369  Millions$ 2.835  Millions
Intercept Pharmaceuticals inc   4.20 $ 451.728  Millions$ 107.676  Millions
Xeris Biopharma Holdings Inc   4.02 $ 221.379  Millions$ 55.040  Millions
Seelos Therapeutics Inc   4.01 $ 31.629  Millions$ 7.879  Millions
Bellicum Pharmaceuticals Inc   3.94 $ 29.532  Millions$ 7.499  Millions
Revance Therapeutics Inc   3.88 $ 565.878  Millions$ 145.713  Millions
Mei Pharma Inc   3.38 $ 126.275  Millions$ 37.308  Millions
Societal Cdmo Inc   3.26 $ 114.970  Millions$ 35.234  Millions
Teva Pharmaceutical Industries Limited  3.13 $ 29,796.000  Millions$ 9,519.000  Millions
Journey Medical Corporation  3.08 $ 80.587  Millions$ 26.184  Millions

Date modified: 2022-10-28T16:01:35+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AAIC's Profile

Stock Price

AAIC's Financials

Business Description

Fundamentals

Charts & Quotes

AAIC's News

Suppliers

AAIC's Competitors

Customers & Markets

Economic Indicators

AAIC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071